Gene signatures derived from genomic, transcriptomic, and immune profiling predict prognosis and response to immune ...
Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations, but it has been difficult to discern whether they play an active role in ...
Colorectal tumors can vary in molecular mutations among individuals and communities, according to a new study from Cedars-Sinai Cancer. Investigators reporting in the journal Cancer Research concluded ...
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, announced today the launch of AML Express, a next-generation sequencing (NGS) assay ...
In a major step towards early detection, University of South Australia researchers are investigating the biology behind multiple sclerosis (MS) to help predict people's genetic risk of developing the ...
The impact of glucagon-like peptide-1 agonists on MGUS progression in patients with type 2 diabetes. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
Scientists at the Broad Institute of MIT and Harvard have identified 4,208 previously unannotated open reading frames (ORFs) across 679 human-associated viral genomes using a high-throughput method ...
GeneCentric, a precision medicine company bringing gene expression biology to liquid biopsy, today announced the launch of ExpressCT Rewind™, a retrospective fragmentomics analysis service that ...
Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results